#ASH19

Samer Al Hadidi, MD MSc

HadidiSamer

QUAZAR just published @NEJM. Maintenance oral AZA resulted in ~10 months longer OS in AML patients in first remission, results should be interpreted with caution:Difference in survival can be related

Mike Thompson, MD, PhD, FASCO

mtmdphd

[THREAD] #ClinicalTrials Eligibility [Updated Mar 11, 2020] #ctsm Modernizing Eligibility Criteria for Molecularly Driven #ClinicalTrials [7/20/15] - @EdKimMDLCI et al. JCO @ASCO_pubs http://ow.ly/RGEdG metRCC Clinical Trial Participa

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.